Circular RNA circ_0042103 and the TAF15/NER Axis in Pulpitis: Molecular Insights

Study Background and Research Question

Pulpitis, characterized by inflammation and tissue destruction in the dental pulp, remains a significant clinical challenge with limited regenerative treatment options. Chronic microbial infection and persistent inflammation can induce DNA damage, particularly double-strand breaks (DSBs), exacerbating tissue injury and impairing repair mechanisms. Recent work has highlighted the roles of circular RNAs (circRNAs)—covalently closed non-coding RNAs—in regulating inflammation and the DNA damage response (DDR) in various tissues. However, the precise molecular pathways by which circRNAs modulate inflammation and DNA repair in pulpitis have not been fully elucidated. The present study investigates whether specific circRNAs, notably circ_0042103, contribute to the progression of pulpitis by influencing inflammatory signaling and DNA repair in dental pulp stem cells (DPSCs).

Key Innovation from the Reference Study

The core innovation of this research lies in identifying a previously uncharacterized regulatory axis: the circ_0042103/TAF15/NER pathway, which links circRNA activity to DNA repair and inflammatory responses in pulpitis. Through a combination of transcriptomic profiling, molecular interaction assays, and functional validation, the authors demonstrate that circ_0042103 directly interacts with the RNA-binding protein TAF15. This interaction diminishes the expression of nucleotide excision repair (NER) proteins ERCC1 and PCNA, thereby aggravating DNA damage and amplifying inflammation in inflamed DPSCs. This mechanistic insight bridges the fields of RNA biology, DNA repair, and oral inflammatory disease, providing a novel conceptual framework for understanding how circRNAs can orchestrate tissue injury.

Methods and Experimental Design Insights

The study employs a robust, multi-layered approach to dissect the molecular underpinnings of pulpitis. The core experimental design includes:

• Transcriptomic Profiling: Microarray and single-cell RNA sequencing are used to identify circRNAs upregulated in inflamed dental pulp and DPSCs, with a focus on DNA damage response pathways.
• Gene and Protein Expression Analyses: Quantitative RT-PCR and Western blotting assess markers of DNA damage (γ-H2AX) and inflammatory cytokines (e.g., IL-6, TNF-α) in pulp tissue samples.
• Functional Assays: DPSCs are subjected to LPS-induced inflammatory stimulation with or without circ_0042103 knockdown or overexpression, evaluating the resultant DDR activation and cytokine production.
• Molecular Interaction Studies: The interaction between circ_0042103 and TAF15 is validated using RNA FISH, RNA pulldown, and nuclear-cytoplasmic fractionation, clarifying subcellular localization and binding specificity.
• Pathway Manipulation: TAF15 knockdown and NER pathway interrogation (via ERCC1 and PCNA expression) determine the functional outcomes of disrupting the circ_0042103/TAF15/NER axis.

This integrated strategy enables the authors to correlate molecular changes with functional outcomes, establishing causality between circ_0042103 activity, DNA repair impairment, and inflammatory exacerbation.

Core Findings and Why They Matter

Several key findings emerge from the study:

• Activation of DDR in Pulpitis: Both inflamed dental pulp tissue and DPSCs exhibit robust activation of DNA damage response pathways, with elevated γ-H2AX and proinflammatory cytokines, confirming the link between chronic inflammation and DNA injury (reference study).
• Circ_0042103 as a Driver of Damage: circ_0042103 is significantly upregulated in inflamed DPSCs. Its overexpression enhances LPS-induced DDR and inflammatory signaling, whereas knockdown mitigates both DNA damage and cytokine output.
• Mechanistic Axis Defined: circ_0042103 physically binds TAF15, resulting in reduced expression of NER pathway proteins (ERCC1, PCNA). This impairs DNA repair capacity, increasing susceptibility to DNA lesions and inflammatory signaling.
• Clinical and Biological Implications: These results delineate a molecular axis whereby circ_0042103 modulates pulpitis pathology by interfering with DNA repair and amplifying inflammation. The findings highlight circ_0042103 and its interaction partners as potential research targets for modulating repair and immune responses in oral tissue injury.

By clarifying how a specific circRNA can orchestrate both DNA repair and inflammatory pathways, the study advances understanding of the molecular crosstalk underlying tissue degeneration in pulpitis and potentially other chronic inflammatory conditions.

Comparison with Existing Internal Articles

Several internal resources contextualize and extend the significance of the reference study:

• Circ_0042103/TAF15/NER Axis Links Circular RNA to Pulpitis Damage summarizes the mechanistic bridge between circ_0042103, DNA repair, and inflammation, reinforcing the reference paper's evidence that specific circRNAs can impair NER and accelerate tissue injury in oral disease models.
• Ribonuclease R (20 U/μL) for Precision Circular RNA Enrichment and Ribonuclease R (20 U/μL): Circular RNA Enrichment in Inflammation Research discuss the technical advances in selectively enriching circRNAs (such as circ_0042103) using linear RNA digestion enzymes. These protocols underpin the ability to accurately profile and functionally interrogate circRNAs in disease models, as was critical in the reference study's workflow.
• Workflow optimization resources, such as Optimizing Circular RNA Enrichment, provide evidence-backed recommendations for maximizing assay sensitivity and reproducibility—parameters essential for reliable circRNA discovery and validation in mechanistic studies.

Together, these internal articles and the reference study form a cohesive framework for understanding how technical advances in circular RNA enrichment and analysis directly support mechanistic investigation of circRNA function in inflammation and DNA repair.

Limitations and Transferability

While the study offers compelling evidence for the circ_0042103/TAF15/NER axis in pulpitis, several limitations warrant careful consideration:

• Model System Constraints: Most functional validation was performed in vitro using human DPSCs. While this system is relevant for pulpitis, in vivo confirmation is required to establish the axis's role in the complex tissue environment.
• Disease Specificity: The findings are directly applicable to dental pulpitis, but the extent to which the same axis operates in other inflammatory or DNA damage-driven diseases remains to be explored.
• Therapeutic Translation: The study identifies research targets (circ_0042103, TAF15, NER components) but does not address the feasibility, safety, or specificity of potential interventions targeting this pathway.

Despite these caveats, the mechanistic insights are broadly transferable to research on the interface between RNA regulation, DNA repair, and inflammation, particularly in tissues where circRNA expression is prominent.

Protocol Parameters

• circRNA enrichment workflow: Employ a linear RNA digestion enzyme such as Ribonuclease R (20 U/μL) to selectively remove linear RNA prior to circRNA profiling, as supported by optimized protocols in recent workflow articles.
• Sample lysis and RNA integrity: Use RNase-free conditions and validated lysis buffers during extraction to preserve RNA quality for downstream qRT-PCR and sequencing.
• Negative controls for interaction assays: Include non-targeting RNA/protein pulldown controls to confirm specificity when validating RNA-protein interactions such as circ_0042103/TAF15 binding.
• Inflammatory stimulation timing: For LPS-induced DDR in DPSCs, preincubate cells with LPS (e.g., 1 μg/mL) for 12–24 hours prior to molecular or functional analyses.
• Transfection efficiency assessment: Quantify circ_0042103 knockdown or overexpression by qRT-PCR before proceeding to downstream assays.

Research Support Resources

To facilitate selective circular RNA enrichment and analysis in similar inflammation or DNA repair studies, researchers can utilize Ribonuclease R (RNase R) (20 U/μL) (SKU K3061), a highly processive 3' to 5' exoribonuclease that efficiently digests linear RNA while sparing circular and structured RNAs. This enzyme, as described in internal protocol articles, is widely integrated into workflows for circular RNA enrichment, structure-function analyses, and validation of circRNA-mediated mechanisms in inflammation research. APExBIO's preparation supports reproducible, high-sensitivity circRNA profiling necessary for dissecting regulatory axes such as circ_0042103/TAF15/NER. Always consult product documentation for storage and handling guidance to maximize experimental reliability.